Antibody quantity versus quality after influenza vaccination. - Wikidata - awgldk - TriplyDB

Antibody quantity versus quality after influenza vaccination.

Antibody quantity versus quality after influenza vaccination.

http://www.wikidata.org/entity/Q42589251

about

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses.Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.Influenza neuraminidase.Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice Pneumonia immunization in older adults: review of vaccine effectiveness and strategies Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine.Human influenza vaccines and assessment of immunogenicity.Immunological assessment of influenza vaccines and immune correlates of protection.Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination."Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza a evolution.Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).

P2860

Q21091074-275DE356-E7D8-471C-920D-440208260664 Q30404512-B7D64141-5379-46EE-AEBF-104805D7C8F0 Q30419865-AB8B2769-1D73-4247-9B32-B4ABADADDCEE Q30424758-52C5423C-134A-4CA2-B0F0-8DCB00608FD9 Q33812439-917A5D05-242E-4643-B884-F1C6332974ED Q35133760-C3393135-91B3-4F4A-A20B-DFC6474CD086 Q35146181-14AB25C5-9FFD-455E-8D41-EDB45D3FFF5F Q35193959-1DD4B2F5-ECE9-409D-8EF0-7B15BDAADE10 Q35602526-7BAFFC97-29FA-4154-BB14-5B7763671693 Q35711767-5A04AEE9-D78D-463F-9A57-69F95F3528B2 Q35791130-243CB083-818F-4E5B-A858-C58610B7D03D Q35797338-992C1EE9-58D9-45B6-8554-10B5448824B2 Q36106575-7F0DF378-2860-43DA-90DC-AB37207567D7 Q36393396-2D69FBE9-CC74-4235-82CE-DBD21DEC8BD7 Q37798007-A0349EF0-203B-4337-95D7-B3827F0BF93F Q37812125-75E38E6D-EBD9-4612-8EEC-35B1A4F3C74E Q38105339-1CAABC64-DE4B-487D-9FCF-78AB346FD0FC Q38374766-84BDF749-6819-4619-8F4E-79665E86640A Q41959544-738F8576-DF47-4F2F-BBFB-6A73FE20BAAE Q50033604-C79FF459-5E4A-43BF-9C8B-AD75B3E50594

P2860

Antibody quantity versus quality after influenza vaccination.

http://www.wikidata.org/entity/Q42589251

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Antibody quantity versus quality after influenza vaccination.

@en

Antibody quantity versus quality after influenza vaccination.

@nl

type

label

Antibody quantity versus quality after influenza vaccination.

@en

Antibody quantity versus quality after influenza vaccination.

@nl

prefLabel

Antibody quantity versus quality after influenza vaccination.

@en

Antibody quantity versus quality after influenza vaccination.

@nl

P1433

Q42589251-DE80058C-420D-4501-8D24-085685CB8164

P1476

Q42589251-18E8D365-13CE-47B9-B8B8-F8610C801BB9

P2093

Q42589251-04E399C4-D88F-405C-838D-DCF5227EABC2

Q42589251-22E542FD-2E2F-4C83-85E1-66C386002485

Q42589251-2B207F55-61C0-48E3-984D-ED3ACF6ED495

Q42589251-9EF2E67A-CF79-4BA2-BB4A-C927C4540171

Q42589251-F6ADDE14-0A78-45B2-98F0-1D91286ECB51

P2860

Q42589251-1334D4EA-0FF5-4BEE-9542-39A98E9B13D7

Q42589251-13FC6E2B-CABB-4F79-A8EB-35D99C30317D

Q42589251-2AA1DEBE-31A2-4754-9327-F6319FA2314E

Q42589251-55436623-F090-471A-A3B8-F7F28F383F1C

Q42589251-5A6CEA0C-FAF8-480C-A440-F39E6EA23649

Q42589251-90BE23AE-FC3D-4A97-804B-61A351647FA9

Q42589251-98C00EBC-03D4-44FA-902A-5C0166A6C68C

Q42589251-9D2DE029-6397-487A-87A7-26F037938D5A

Q42589251-A121CC9A-4AF3-4C80-8BA3-A2D15CF05D6C

Q42589251-A5DC2974-CFBA-4C25-9190-B6978E126920

P304

Q42589251-C01BF640-15A7-4D1E-AEC4-FFF12AB9D746

P31

Q42589251-104C7421-9396-4070-9A79-22B0A5FF24A0

P356

Q42589251-57042E1D-CFDB-432F-A6D3-B9D9AA3C62BB

P407

Q42589251-21C4B2CD-9AF9-46B7-A249-E1EEA44EBB3D

P433

Q42589251-8331FD96-E550-4483-B310-AE3C4C5CD53F

P478

Q42589251-A2353554-724B-48EC-83F4-55DA0FF9A94B

P50

Q42589251-83A6416C-2438-492A-9113-105A6B93B3FB

Q42589251-84BF08BD-1399-4CBA-AF3C-A2E84E5BE03A

Q42589251-9739FB85-CD2A-4BFB-8688-D86965934323

P577

Q42589251-046D5337-F18F-4223-83A2-7E4253E32B15

P5875

Q42589251-6643437E-8267-4BE9-8BD5-35AE421F2EF2

P698

Q42589251-2AFFC9B7-99B9-4D75-8FC5-31EB7B5EB8F9

P921

Q42589251-8312E572-F70D-4C1C-A2A9-1F993AE93919

P932

Q42589251-BFF89E5D-1B78-42C5-8D2B-196233524D47

P356

J.VACCINE.2009.06.090

P1433

P1476

Antibody quantity versus quality after influenza vaccination.

@en

P2093

David M Thompson

http://www.w3.org/2001/XMLSchema#string

JingQi Feng

http://www.w3.org/2001/XMLSchema#string

Linda F Thompson

http://www.w3.org/2001/XMLSchema#string

Upma Gulati

http://www.w3.org/2001/XMLSchema#string

Xiaoju Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.

Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin.

Epitopes on protein antigens: misconceptions and realities.

Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination.

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses.

Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination.

P304

6358-6362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.06.090

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Judith A. James

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38021730

http://www.w3.org/2001/XMLSchema#string

P698

19840673

http://www.w3.org/2001/XMLSchema#string

P921

P932

2765411

http://www.w3.org/2001/XMLSchema#string